A selective decrease in the number of GABAergic somata occurs in pre-seizing monkeys with alumina gel granuloma.

Area of Science:

• Neuroscience
• Epilepsy Research
• Cellular Biology

Background:

• Previous studies indicate a correlation between GABAergic neuronal somata loss and terminal loss in chronic epileptic foci.
• The role of GABAergic neuronal loss in the preclinical stages of epilepsy remains to be fully elucidated.

Purpose of the Study:

• To investigate whether GABAergic neuronal loss precedes the onset of clinical seizures in alumina gel-induced epilepsy models in monkeys.
• To determine the extent of GABAergic neuronal loss in pre-seizing and chronically seizing animals.

Main Methods:

• Alumina gel implants were used to induce epilepsy in adolescent rhesus monkeys (Macaca mulatta).
• Tissue sections from pre-seizing, chronically seizing, and control monkeys were analyzed using glutamate decarboxylase (GAD) immunocytochemistry and Nissl staining.
• Quantitative analysis of GAD-positive cells and total neurons was performed at the epileptic focus, parafocal, and contralateral sites.

Main Results:

• A significant decrease in GAD-positive cells was observed in both pre-seizing (23-44% loss at focus) and chronically seizing (42-61% loss at focus) monkeys.
• Total neuron counts remained unchanged in pre-seizing monkeys but showed a significant loss (11-61%) at the focus in chronically seizing animals.
• Control and surgical control groups exhibited no significant loss of GAD-positive cells or total neurons.

Conclusions:

• Selective loss of GABAergic (GAD-positive) neurons occurs in the sensorimotor cortex prior to the development of clinical seizures in an alumina gel-induced epilepsy model.
• These findings support the hypothesis that GABAergic neuronal loss is a critical factor in the pathogenesis of focal epilepsy.
• The study highlights the importance of GABAergic system integrity in preventing seizure onset.